Cargando…
Pharmacokinetics of Bismuth following Oral Administration of Wei Bi Mei in Healthy Chinese Volunteers
BACKGROUND: Bismuth-containing quadruple therapy achieves higher eradication rate of Helicobacter pylori. High level of bismuth in blood may result in damage of many organs. Wei Bi Mei is a new bismuth-containing drug combining chemicals and Chinese medicine portions. The present research is to stud...
Autores principales: | Zhang, Lingye, Liu, Juan, Meng, Fandong, Guan, Yingying, Wang, Yongjun, Zhu, Shengtao, Liu, Yaqiong, Xie, Qing, Yu, Junxian, Zhang, Shutian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442995/ https://www.ncbi.nlm.nih.gov/pubmed/32855646 http://dx.doi.org/10.1155/2020/2679034 |
Ejemplares similares
-
Efficacy and Safety of Wei Bi Mei, a Chinese Herb Compound, as an Alternative to Bismuth for Eradication of Helicobacter pylori
por: Li, Lei, et al.
Publicado: (2018) -
The role of GTPase-activating protein ARHGAP26 in human cancers
por: Zhang, Lingye, et al.
Publicado: (2021) -
Responses to Comments of Weis
por: Guo, Na, et al.
Publicado: (2010) -
The impact of co-administration of ketoconazole and rifampicin on the pharmacokinetics of apremilast in healthy volunteers
por: Liu, Yong, et al.
Publicado: (2014) -
Structural insights reveal the specific recognition of meiRNA by the Mei2 protein
por: Shen, Siyuan, et al.
Publicado: (2022)